- Aug 2022
-
-
Monto, A. S. (2021). The Future of SARS-CoV-2 Vaccination—Lessons from Influenza. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMp2113403
-
- Apr 2022
-
www.scientificamerican.com www.scientificamerican.com
-
Wallis, C. (n.d.). COVID Has Pushed Medical Research into Remote Trials, Benefiting Patients and Scientists. Scientific American. https://doi.org/10.1038/scientificamerican0521-24
-
-
twitter.com twitter.com
-
The Lancet. (2021, April 16). Quantity > quality? The magnitude of #COVID19 research of questionable methodological quality reveals an urgent need to optimise clinical trial research—But how? A new @LancetGH Series discusses challenges and solutions. Read https://t.co/z4SluR3yuh 1/5 https://t.co/94RRVT0qhF [Tweet]. @TheLancet. https://twitter.com/TheLancet/status/1383027527233515520
-
-
www.ema.europa.eu www.ema.europa.eu
-
EMA. (2020, October 27). COVID-19 vaccines: Development, evaluation, approval and monitoring [Text]. European Medicines Agency. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-development-evaluation-approval-monitoring
-
- Jan 2022
-
medicalxpress.com medicalxpress.com
-
Tong-Hyung, K. (n.d.). South Korea gets first supply of Pfizer’s COVID-19 pills. Retrieved January 20, 2022, from https://medicalxpress.com/news/2022-01-south-korea-pfizer-covid-pills.html
-
-
twitter.com twitter.com
-
Shematologist, MD. (2022, January 13). In medicine this is what we call a conflict of interest. Https://t.co/DNk0pDdz6Y [Tweet]. @acweyand. https://twitter.com/acweyand/status/1481480271254138880
-
- Dec 2021
-
erictopol.substack.com erictopol.substack.com
-
Topol, E. (2021, December 16). Why Paxlovid is a Just-in-Time Breakthrough [Substack newsletter]. Ground Truths. https://erictopol.substack.com/p/why-paxlovid-is-a-just-in-time-breakthrough
-
- Oct 2021
-
www.science.org www.science.org
-
Mateus, J., Dan, J. M., Zhang, Z., Rydyznski Moderbacher, C., Lammers, M., Goodwin, B., Sette, A., Crotty, S., & Weiskopf, D. (n.d.). Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells. Science, 0(0), eabj9853. https://doi.org/10.1126/science.abj9853
-
-
www.cloverbiopharma.com www.cloverbiopharma.com
-
Clover’s COVID-19 Vaccine Candidate Demonstrates 79% Efficacy Against Delta in Global Phase 2/3 SPECTRA Trial Dominated by Variants of Concern and Interest—Clover Biopharmaceuticals. (n.d.). Retrieved 4 October 2021, from https://www.cloverbiopharma.com/news/83.html
-
- Sep 2021
-
www.nytimes.com www.nytimes.com
-
Zimmer, C., Corum, J., & Wee, S.-L. (2020, June 10). Coronavirus Vaccine Tracker. The New York Times. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
-
-
www.newscientist.com www.newscientist.com
-
Klein, Alice. “Cheap Covid-19 Antibody Test Shows If You Have Immunity in 5 Minutes.” New Scientist. Accessed September 20, 2021. https://www.newscientist.com/article/2290120-cheap-covid-19-antibody-test-shows-if-you-have-immunity-in-5-minutes/.
Tags
- immunity
- blood
- accuracy
- lang:en
- COVID-19
- protection
- infection
- clinical trial
- is:news
- vaccination
- approval
- antibody
- Coronavirus
- fast
- saliva
- cheap
Annotators
URL
-
- Aug 2021
-
www.nytimes.com www.nytimes.com
-
Mandavilli, A. (2021, August 6). New data suggest J. & J. vaccine works against Delta and recipients don’t need a booster shot. The New York Times. https://www.nytimes.com/2021/08/06/science/johnson-delta-vaccine-booster.html
-
- Jul 2021
-
www.theguardian.com www.theguardian.com
-
the Guardian. ‘Israel Says 600 Children given Covid Jab Had No Serious Side-Effects’, 10 March 2021. http://www.theguardian.com/society/2021/mar/10/israel-says-600-children-given-covid-jab-had-no-serious-side-effects.
-
- Jun 2021
-
www.henryford.com www.henryford.com
-
Here’s Where That COVID-19 Vaccine Infertility Myth Came From—And Why It Is Not True. (n.d.). Retrieved June 18, 2021, from https://www.henryford.com/blog/2021/04/fertility-rumor-covid-vaccine
-
-
www.nature.com www.nature.com
-
Remmel, A. (2021). COVID vaccines and safety: What the research says. Nature, 590(7847), 538–540. https://doi.org/10.1038/d41586-021-00290-x
-
-
www.theguardian.com www.theguardian.com
-
Moderna jab stops Covid transmission in people aged 12 to 18, trial finds. (2021, May 25). The Guardian. http://www.theguardian.com/world/2021/may/25/moderna-jab-stops-covid-transmission-in-people-aged-12-to-18-trial-finds
-
- May 2021
-
www.theguardian.com www.theguardian.com
-
Misinformation “superspreaders”: Covid vaccine falsehoods still thriving on Facebook and Instagram. (2021, January 6). The Guardian. http://www.theguardian.com/world/2021/jan/06/facebook-instagram-urged-fight-deluge-anti-covid-vaccine-falsehoods
-
-
-
Chastain, D. B., Osae, S. P., Henao-Martínez, A. F., Franco-Paredes, C., Chastain, J. S., & Young, H. N. (2020). Racial Disproportionality in Covid Clinical Trials. New England Journal of Medicine. https://doi.org/10.1056/NEJMp2021971
-
-
twitter.com twitter.com
-
Eric Topol. (2021, February 17). New reports @NEJM today confirming some immune evasion of the B.1.351 variant (identified in South Africa) to both the mRNA vaccines, in vitro data @BioNTech_Group/@Pfizer and @moderna_tx. Less vaccine efficacy vs B.1.351 has been confirmed in clinical trials for 3 vaccines https://t.co/2N7eKDllso [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1362160675913568256
-
-
www.thelancet.com www.thelancet.com
-
Park, J. J. H., Ford, N., Xavier, D., Ashorn, P., Grais, R. F., Bhutta, Z. A., Goossens, H., Thorlund, K., Socias, M. E., & Mills, E. J. (2021). Randomised trials at the level of the individual. The Lancet Global Health, 9(5), e691–e700. https://doi.org/10.1016/S2214-109X(20)30540-4
-
-
www.thelancet.com www.thelancet.com
-
Dron, L., Taljaard, M., Cheung, Y. B., Grais, R., Ford, N., Thorlund, K., Jahan, F., Nakimuli-Mpungu, E., Xavier, D., Bhutta, Z. A., Park, J. J. H., & Mills, E. J. (2021). The role and challenges of cluster randomised trials for global health. The Lancet Global Health, 9(5), e701–e710. https://doi.org/10.1016/S2214-109X(20)30541-6
-
-
www.thelancet.com www.thelancet.com
-
Park, J. J. H., Mogg, R., Smith, G. E., Nakimuli-Mpungu, E., Jehan, F., Rayner, C. R., Condo, J., Decloedt, E. H., Nachega, J. B., Reis, G., & Mills, E. J. (2021). How COVID-19 has fundamentally changed clinical research in global health. The Lancet Global Health, 9(5), e711–e720. https://doi.org/10.1016/S2214-109X(20)30542-8
-
-
www.thelancet.com www.thelancet.com
-
Park, J. J. H., Grais, R. F., Taljaard, M., Nakimuli-Mpungu, E., Jehan, F., Nachega, J. B., Ford, N., Xavier, D., Kengne, A. P., Ashorn, P., Socias, M. E., Bhutta, Z. A., & Mills, E. J. (2021). Urgently seeking efficiency and sustainability of clinical trials in global health. The Lancet Global Health, 9(5), e681–e690. https://doi.org/10.1016/S2214-109X(20)30539-8
-
- Mar 2021
-
www.thelancet.com www.thelancet.com
-
Iversen, P. L., & Bavari, S. (2021). Is there space for a three-dose vaccine to fight the spread of SARS-CoV-2? The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00149-3
-
-
www.thelancet.com www.thelancet.com
-
Clinical trials of disease stages in COVID 19: Complicated and often misinterpreted—The Lancet Global Health. (n.d.). Retrieved August 24, 2020, from https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30365-X/fulltext
-
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
Rosendaal, F. R. (2020). Review of: “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949. International Journal of Antimicrobial Agents, 106063. https://doi.org/10.1016/j.ijantimicag.2020.106063
-
-
Local file Local file
-
Smith, P. (2021). Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca. WHO.
-
-
www.washingtonpost.com www.washingtonpost.com
-
Isaacson, Walter. ‘Opinion | I Was Part of a Trial for Pfizer’s Covid-19 Vaccine. It’s a Miracle for Genetic Medicine.’ Washington Post. Accessed 6 March 2021. https://www.washingtonpost.com/opinions/i-took-the-pfizer-covid-19-vaccine-its-a-miracle-for-genetic-medicine/2020/11/09/77e652d0-22bf-11eb-952e-0c475972cfc0_story.html.
-
-
www.frontiersin.org www.frontiersin.org
-
Abdelhafiz, Ahmed Samir, Samar Abd ElHafeez, Mohammad Adnan Khalil, Manal Shahrouri, Bandar Alosaim, Raneem O. Salem, Mohamed Alorabi, Fatma Abdelgawad, and Mamoun Ahram. ‘Factors Influencing Participation in COVID-19 Clinical Trials: A Multi-National Study’. Frontiers in Medicine 8 (2021). https://doi.org/10.3389/fmed.2021.608959.
-
-
www-nature-com.ezp.lib.cam.ac.uk www-nature-com.ezp.lib.cam.ac.uk
-
Nature Editorial. (2020, October 23). The race to make COVID antibody therapies cheaper and more potent. Nature. https://www.nature.com/articles/d41586-020-02965-3?utm_source=twt_nnc&utm_medium=social&utm_campaign=naturenews&sf239165668=1&error=cookies_not_supported&code=2b2dd7c6-d01f-4057-8389-3be656a7ba58
-
-
academic.oup.com academic.oup.com
-
Meng Z , Wang T , Li C et al. PREPRINT: An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area. medRxiv 2020:2020.04.11.20061473. doi:10.1101/2020.04.11.20061473.
-
-
academic.oup.com academic.oup.com
-
Meng Z , Wang T , Li C et al. PREPRINT: An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area. medRxiv 2020:2020.04.11.20061473.
-
- Feb 2021
-
twitter.com twitter.com
-
Dr Ellie Murray. (2020, December 3). Some really great resources & discussions in this thread. The tl;dr is (1) yes, the vaccine trials included some people who had previously had COVID; and (2) in general vaccination plans will include those who have previously been sick/infected. Thanks all! [Tweet]. @EpiEllie. https://twitter.com/EpiEllie/status/1334545373126389766
-
-
www.cdc.gov www.cdc.gov
-
Gee, Julianne. ‘First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021’. MMWR. Morbidity and Mortality Weekly Report 70 (2021). https://doi.org/10.15585/mmwr.mm7008e3.
-
-
www.nihr.ac.uk www.nihr.ac.uk
-
Novavax COVID-19 vaccine 89.3% effective. (n.d.). Retrieved 1 February 2021, from https://www.nihr.ac.uk/news/novavax-covid-19-vaccine-893-effective/26720
-
- Jan 2021
-
www.news-medical.net www.news-medical.net
-
Analysis supports phase 3 trials of Johnson & Johnson’s COVID-19 vaccine. (2021, January 17). News-Medical.Net. https://www.news-medical.net/news/20210117/Analysis-supports-phase-3-trials-of-Johnson-Johnsons-COVID-19-vaccine.aspx
-
-
www.nejm.org www.nejm.org
-
Sadoff, J., Le Gars, M., Shukarev, G., Heerwegh, D., Truyers, C., de Groot, A. M., Stoop, J., Tete, S., Van Damme, W., Leroux-Roels, I., Berghmans, P.-J., Kimmel, M., Van Damme, P., de Hoon, J., Smith, W., Stephenson, K. E., De Rosa, S. C., Cohen, K. W., McElrath, M. J., … Schuitemaker, H. (2021). Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine. New England Journal of Medicine, 0(0), null. https://doi.org/10.1056/NEJMoa2034201
-
-
twitter.com twitter.com
-
ReconfigBehSci on Twitter: “RT @DrJV75: Some great vaccine myth busting summary images to share https://t.co/MeSjC89eu4” / Twitter. (n.d.). Retrieved January 13, 2021, from https://twitter.com/SciBeh/status/1335893630951755778
-
-
www.theatlantic.com www.theatlantic.com
-
Zhang, S. (2020, September 28). Vaccine Chaos Is Looming. The Atlantic. https://www.theatlantic.com/health/archive/2020/09/covid-19-most-complicated-vaccine-campaign-ever/616521/
-
- Dec 2020
-
www.nature.com www.nature.com
-
Cyranoski, D. (2020). Arab nations first to approve Chinese COVID vaccine—Despite lack of public data. Nature, 588(7839), 548–548. https://doi.org/10.1038/d41586-020-03563-z
-
-
www.nature.com www.nature.com
-
Ledford, H., Cyranoski, D., & Noorden, R. V. (2020). The UK has approved a COVID vaccine—Here’s what scientists now want to know. Nature, 588(7837), 205–206. https://doi.org/10.1038/d41586-020-03441-8
-
-
www.nature.com www.nature.com
-
Ledford, H. (2020). Oxford COVID-vaccine paper highlights lingering unknowns about results. Nature. https://doi.org/10.1038/d41586-020-03504-w
-
-
www.thelancet.com www.thelancet.com
-
Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K., Duncan, C. J. A., … Zuidewind, P. (2020). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)32661-1
-
- Sep 2020
-
www.nature.com www.nature.com
-
magazine, D. C., Smriti Mallapaty,Nature. (n.d.). Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency. Scientific American. Retrieved September 16, 2020, from https://www.scientificamerican.com/article/coronavirus-vaccine-u-k-trial-restarts-but-scientists-question-lack-of-transparency/
-
-
www.bmj.com www.bmj.com
-
Siemieniuk, R. A., Bartoszko, J. J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Rochwerg, B., Lamontagne, F., Han, M. A., Liu, Q., Agarwal, A., Agoritsas, T., Chu, D. K., Couban, R., Darzi, A., Devji, T., Fang, B., Fang, C., … Brignardello-Petersen, R. (2020). Drug treatments for covid-19: Living systematic review and network meta-analysis. BMJ, 370. https://doi.org/10.1136/bmj.m2980
-
-
jamanetwork.com jamanetwork.com
-
Kouzy, R., Jaoude, J. A., Garcia, C. J. G., Alam, M. B. E., Taniguchi, C. M., & Ludmir, E. B. (2020). Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. JAMA Network Open, 3(7), e2015100–e2015100. https://doi.org/10.1001/jamanetworkopen.2020.15100
-
-
www.youtube.com www.youtube.com
-
JNOLive | Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019. (2020, July 14). https://www.youtube.com/watch?v=H-MWPqgLUvA&feature=youtu.be
-
-
www.scientificamerican.com www.scientificamerican.com
-
Ponchner, D. (n.d.). Costa Rica Readies Horse Antibodies for Trials as an Inexpensive COVID-19 Therapy. Scientific American. Retrieved September 8, 2020, from https://www.scientificamerican.com/article/costa-rica-readies-horse-antibodies-for-trials-as-an-inexpensive-covid-19-therapy/
Tags
- development
- lang:en
- Costa Rica
- COVID-19
- low-cost
- therapy
- immunology
- clinical trial
- intervention
- is:news
- horse antibodies
- human research
Annotators
URL
-
-
www.nytimes.com www.nytimes.com
-
Emanuel, E. J., & Offit, P. A. (2020, June 8). Opinion | Could Trump Turn a Vaccine Into a Campaign Stunt? The New York Times. https://www.nytimes.com/2020/06/08/opinion/trump-coronavirus-vaccine.html
-
-
www.thelancet.com www.thelancet.com
-
Rheumatology, T. L. (2020). COVID-19: A time to reflect. The Lancet Rheumatology, 2(6), e309. https://doi.org/10.1016/S2665-9913(20)30102-8
-
- Aug 2020
-
www.siliconrepublic.com www.siliconrepublic.com
-
Gorey, C. (2020, June 29). RCSI team to start trial for promising Covid-19 therapy for severe infections. Silicon Republic. https://www.siliconrepublic.com/innovation/rcsi-trial-covid-19-therapy-alpha-1-antitrypsin
-
-
pubs.acs.org pubs.acs.org
-
Shan, B., Broza, Y. Y., Li, W., Wang, Y., Wu, S., Liu, Z., Wang, J., Gui, S., Wang, L., Zhang, Z., Liu, W., Zhou, S., Jin, W., Zhang, Q., Hu, D., Lin, L., Zhang, Q., Li, W., Wang, J., … Haick, H. (2020). Multiplexed Nanomaterial-Based Sensor Array for Detection of COVID-19 in Exhaled Breath. ACS Nano. https://doi.org/10.1021/acsnano.0c05657
-
-
www.medrxiv.org www.medrxiv.org
-
Mohana, A., Suliman, T., Mahmoud, N., Hassanein, M., Alfaifi, A., Alenazi, E., Radwan, N., Alkhalifah, N., Elkady, E., Almohaizeie, A., AboGazalah, F., AbdulKareem, K., AlGhofaili, F., Jokhdar, H., & Alrabiah, F. (2020). Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia. MedRxiv, 2020.08.16.20175752. https://doi.org/10.1101/2020.08.16.20175752
-
-
www.youtube.com www.youtube.com
-
Science Facebook Live: Understanding SARS-CoV-2 structure informs vaccine design, clinical trials. (2020, March 20). https://www.youtube.com/watch?v=nOzEx3OpKe8
-
-
www.ijidonline.com www.ijidonline.com
-
Monforte, A. d’Arminio, Tavelli, A., Bai, F., Marchetti, G., & Cozzi-Lepri, A. (2020). Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal? International Journal of Infectious Diseases, 99, 75–76. https://doi.org/10.1016/j.ijid.2020.07.056
-
-
-
Mather, N. (2020). How we accelerated clinical trials in the age of coronavirus. Nature, 584(7821), 326–326. https://doi.org/10.1038/d41586-020-02416-z
-
-
www.nber.org www.nber.org
-
Lo, A. W., Siah, K. W., & Wong, C. H. (2020). Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs (Working Paper No. 27176; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27176
-
-
www.nber.org www.nber.org
-
Chaudhuri, S., Lo, A. W., Xiao, D., & Xu, Q. (2020). Bayesian Adaptive Clinical Trials for Anti‐Infective Therapeutics during Epidemic Outbreaks (Working Paper No. 27175; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27175
-
-
jamanetwork.com jamanetwork.com
-
Khan MS, Fonarow GC, Friede T, et al. Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results. JAMA Netw Open. 2020;3(8):e2012469. doi:10.1001/jamanetworkopen.2020.12469
-
-
www.nber.org www.nber.org
-
Kominers, S. D., Pathak, P. A., Sönmez, T., & Ünver, M. U. (2020). Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design (Working Paper No. 27143; Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w27143
-
-
www.medrxiv.org www.medrxiv.org
-
Horby, P., Mafham, M., Linsell, L., Bell, J. L., Staplin, N., Emberson, J. R., Wiselka, M., Ustianowski, A., Elmahi, E., Prudon, B., Whitehouse, A., Felton, T., Williams, J., Faccenda, J., Underwood, J., Baillie, J. K., Chappell, L., Faust, S. N., Jaki, T., … Landray, M. J. (2020). Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. MedRxiv, 2020.07.15.20151852. https://doi.org/10.1101/2020.07.15.20151852
-
-
www.cnn.com www.cnn.com
-
CNN, J. G., Naomi Thomas, Dana Vigue and Jacqueline Howard. (n.d.). Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest. CNN. Retrieved August 2, 2020, from https://www.cnn.com/2020/07/20/health/oxford-covid-19-vaccine-results-cansino-pfizer-study/index.html
-
- Jul 2020
-
-
Sehgal, D. (2020). Analysis of Vaccines to tackle COVID-19 with Patent Review [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/q96wj
-
-
www.statnews.com www.statnews.com
-
Herper, M. (2020, July 1). Covid-19 vaccine from Pfizer and BioNTech shows positive results. CNBC. https://www.cnbc.com/2020/07/01/coronavirus-vaccine-from-pfizer-and-biontech-shows-positive-results-report-says.html
-
-
www.medrxiv.org www.medrxiv.org
-
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S. P., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., Li, P., Koury, K., Kalina, W., Cooper, D., Fonter-Garfias, C., Shi, P.-Y., Tuereci, O., Tompkins, K. R., Walsh, E. E., … Jansen, K. U. (2020). Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report. MedRxiv, 2020.06.30.20142570. https://doi.org/10.1101/2020.06.30.20142570
-
-
www.nationalgeographic.com www.nationalgeographic.com
-
A COVID-19 vaccine has passed its first human trial. But is it the frontrunner? (2020, May 29). Science. https://www.nationalgeographic.com/science/2020/05/coronavirus-vaccine-passes-first-human-trial-but-is-it-frontrunner-cvd/
-
-
-
Richards, A. D. (2020). Ethical Guidelines for Deliberately Infecting Volunteers with COVID-19 [Preprint]. SocArXiv. https://doi.org/10.31235/osf.io/jb7gq
-
-
www.clinicalmicrobiologyandinfection.com www.clinicalmicrobiologyandinfection.com
-
Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm-Vernez, I., Zimmer, G., Agoritsas, T., Stirnemann, J., Spechbach, H., Guessous, I., Stringhini, S., Pugin, J., Roux-Lombard, P., Fontao, L., Siegrist, C.-A., Eckerle, I., Vuilleumier, N., & Kaiser, L. (2020). Validation of a commercially available SARS-CoV-2 serological immunoassay. Clinical Microbiology and Infection, 0(0). https://doi.org/10.1016/j.cmi.2020.06.024
-
-
www.biorxiv.org www.biorxiv.org
-
Corbett, K. S., Edwards, D., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., Dinnon, K. H., Elbashir, S. M., Shaw, C. A., Woods, A., Fritch, E. J., Martinez, D. R., Bock, K. W., Minai, M., Nagata, B. M., … Graham, B. S. (2020). SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness. BioRxiv, 2020.06.11.145920. https://doi.org/10.1101/2020.06.11.145920
-
-
www.frontiersin.org www.frontiersin.org
-
Zhou, Q., Chen, V., Shannon, C. P., Wei, X.-S., Xiang, X., Wang, X., Wang, Z.-H., Tebbutt, S. J., Kollmann, T. R., & Fish, E. N. (2020). Interferon-α2b Treatment for COVID-19. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.01061
-
- Jun 2020
-
www.medrxiv.org www.medrxiv.org
-
Chen, L., Zhang, Z., Fu, J., Feng, Z., Zhang, S.-Z., Han, Q.-Y., Zhang, X., Xiao, X., Chen, H.-M., Liu, L.-L., Chen, X.-L., Lan, Y.-P., Zhong, D.-J., Hu, L., Wang, J.-H., Yu, X.-H., She, D.-Y., Zhu, Y.-H., & Yin, Z.-Y. (2020). Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: A prospective open-label randomized controlled study. MedRxiv, 2020.06.19.20136093. https://doi.org/10.1101/2020.06.19.20136093
-
-
www.medrxiv.org www.medrxiv.org
-
Sbidian, E., Josse, J., Lemaitre, G., Mayer, I., Bernaux, M., Gramfort, A., Lapidus, N., Paris, N., Neuraz, A., Lerner, I., Garcelon, N., Rance, B., Grisel, O., Moreau, T., Bellamine, A., Wolkenstein, P., Varoquaux, G., Caumes, E., Lavielle, M., … Audureau, E. (2020). Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: A cohort study of 4,642 in-patients in France. MedRxiv, 2020.06.16.20132597. https://doi.org/10.1101/2020.06.16.20132597
-
-
-
Kurzweil, R. (2020 May 19). AI-Powered Biotech Can Help Deploy a Vaccine In Record Time. Wired. https://www.wired.com/story/opinion-ai-powered-biotech-can-help-deploy-a-vaccine-in-record-time/
-
- May 2020
-
www.ukcdr.org.uk www.ukcdr.org.uk
-
UKCDR - COVID-19 Research Project Tracker
-
-
psyarxiv.com psyarxiv.com
-
Wagenmakers, E., & Gronau, Q. F. (2020, April 27). Efficacy of Hydroxychloroquine in Patients with COVID-19 (Chen et al., 2020): Moderate Evidence for a Treatment Effect on Pneumonia. Retrieved from psyarxiv.com/7nk8z
-
- Apr 2020
-
www.thelancet.com www.thelancet.com
-
Mullard, A. (2020). Flooded by the torrent: The COVID-19 drug pipeline. The Lancet, 395(10232), 1245–1246. https://doi.org/10.1016/S0140-6736(20)30894-1
-